Literature DB >> 10424779

Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors.

C Wenbin1, A Asai, A Teramoto, N Sanno, T Kirino.   

Abstract

Pituitary adenoma is a common neoplasm accounting for 10% of all intracranial tumors. Although the molecular mechanisms underlying the formation of these tumors are largely unknown, a small portion of pituitary adenomas occur in patients with the multiple endocrine neoplasia syndrome type 1 (MEN 1). Although two groups in the United States and Canada have recently reported that sporadic pituitary adenomas very rarely harbor a somatic mutation in the MEN1, MEN1 gene mutation analysis in sporadic pituitary adenomas has not yet been carried out in the Japanese population. To elucidate the potential etiological role of the MEN1 gene in the formation of sporadic pituitary adenomas in Japan, we investigated 40 Japanese patients with sporadic pituitary adenomas (16 hormone-secreting and 24 nonsecreting tumors) for MEN1 gene mutation. Polymerase chain reaction-single-stranded DNA conformation polymorphism analysis and sequencing demonstrated a somatic mutation in the MEN1 gene in only one of the 40 tumors, a prolactinoma, which had a 1-bp deletion in the coding sequence of exon 2. The data suggest that somatic mutations in the MEN1 gene do not play a prominent role in the pathogenesis of sporadic pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424779     DOI: 10.1016/s0304-3835(99)00111-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Pathogenesis of prolactinomas.

Authors:  Anna Spada; Giovanna Mantovani; Andrea Lania
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

3.  MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.

Authors:  Henriett Butz; István Likó; Sándor Czirják; Péter Igaz; Márta Korbonits; Károly Rácz; Attila Patócs
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

Review 4.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

5.  Genetic analysis of a patient with coexisting acromegaly, thyroid papillary carcinoma and subcutaneous fibroma.

Authors:  Jingfang Liu; Xulei Tang; Jianguo Cheng; Liting Wang; Xiaomei Yang; Yan Wang
Journal:  Oncol Lett       Date:  2014-12-23       Impact factor: 2.967

Review 6.  The Genetics of Pituitary Adenomas.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  J Clin Med       Date:  2019-12-21       Impact factor: 4.241

7.  The genome-wide mutational landscape of pituitary adenomas.

Authors:  Zhi-Jian Song; Zachary J Reitman; Zeng-Yi Ma; Jian-Hua Chen; Qi-Lin Zhang; Xue-Fei Shou; Chuan-Xin Huang; Yong-Fei Wang; Shi-Qi Li; Ying Mao; Liang-Fu Zhou; Bao-Feng Lian; Hai Yan; Yong-Yong Shi; Yao Zhao
Journal:  Cell Res       Date:  2016-09-27       Impact factor: 25.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.